Carbamazepine Price Trend and Forecast 2026-2027

Carbamazepine prices in Germany, the highest-cost reporting region, rose 6.0% in H1 2026, climbing from USD 54.9/KG in Q1 to USD 58.2/KG by Q2 as recovering epilepsy, trigeminal neuralgia, and bipolar disorder formulation procurement and firmer iminodibenzyl synthesis intermediate costs reversed the brief Q4 2025 market correction. Globally, the average rose from USD 39.14/KG in Q1 to USD 41.49/KG in Q2, a 6.0% gain. For H2 2026, a global average of USD 40.3-45.3/KG is expected, with continued firming on Middle East supply disruptions and growing anticonvulsant, trigeminal neuralgia, and bipolar mood stabiliser sector demand globally.

Carbamazepine is a dibenzazepine anticonvulsant and mood stabiliser produced by multi-step synthesis from iminodibenzyl precursor through N-chlorocarbonyl ring closure or reaction with cyanogen bromide to yield the 5H-dibenz[b,f]azepine-5-carboxamide active pharmaceutical ingredient. The compound inhibits neuronal firing by use-dependent and voltage-dependent blockade of voltage-gated sodium channels, stabilising inactivated channel conformations and reducing high-frequency repetitive discharge in epileptic neuronal circuits and in ectopic trigeminal sensory nucleus firing driving trigeminal neuralgia pain. The largest pull comes from epilepsy pharmacotherapy, where carbamazepine remains a first-line option in national treatment guidelines for focal partial seizures and continues as a low-cost generic in essential medicine programmes globally. Trigeminal neuralgia first-line therapy and bipolar type I manic episode and maintenance mood stabilisation add significant further demand. Neuropathic pain management in diabetic peripheral neuropathy and postherpetic neuralgia, essential medicine programme supply chains including low-cost generic carbamazepine tablet formulation, and supervised alcohol withdrawal seizure prevention add consistent further volumes. Iminodibenzyl synthesis costs, epilepsy and trigeminal neuralgia prescription volumes, and regional API production capacity all feed into the price.

Carbamazepine Price Forecast for 2026

The balance of supply and demand for Carbamazepine through H2 2026 leans moderately firm. Iminodibenzyl synthesis intermediate costs firmed from Middle East chemical supply disruptions. Epilepsy, trigeminal neuralgia, and bipolar disorder demand are growing with expanding neurological treatment access globally.

The main upside risk is synthesis intermediate cost increases alongside accelerating essential medicine programme procurement. The main downside risk is oxcarbazepine and newer-generation antiepileptic prescribing preference and Chinese and Indian API surplus maintaining price pressure below forecast.

For the Quarter Ending June 2026

Carbamazepine Prices Q2 2026:

• United States: USD 47.2/KG
• China: USD 32.6/KG
• Germany: USD 58.2/KG
• India: USD 44.9/KG

Carbamazepine Prices in the United States

US Carbamazepine prices averaged USD 47.2/KG in Q2 2026, up 6.1% from USD 44.5/KG in Q1 2026. Firmer synthesis intermediate costs and recovering epilepsy and trigeminal neuralgia procurement drove consistent buying through the quarter.

Why did the price of Carbamazepine change in Q2 2026 in the United States?

Firmer iminodibenzyl synthesis intermediate costs raised the API production floor. Epilepsy focal seizure, trigeminal neuralgia, and bipolar disorder formulation procurement lifted buying. Neuropathic pain and essential medicine programme demand provided additional support near USD 47.2/KG.

Carbamazepine Prices in China

Chinese Carbamazepine prices averaged USD 32.6/KG in Q2 2026, up 5.8% from USD 30.8/KG in Q1 2026, the lowest among the tracked markets. Spring epilepsy and neuralgia export and domestic procurement lifted buying. Firmer domestic synthesis costs raised the floor despite large domestic API capacity.

Why did the price of Carbamazepine change in Q2 2026 in China?

Spring epilepsy and trigeminal neuralgia export and domestic procurement lifted buying. Firmer domestic iminodibenzyl synthesis costs raised the production floor. Large domestic API capacity kept China the most affordable source.

Carbamazepine Prices in Germany

German Carbamazepine prices averaged USD 58.2/KG in Q2 2026, up 6.0% from USD 54.9/KG in Q1 2026, the highest among the tracked markets. Higher synthesis intermediate and energy costs elevated European API production economics. Recovering epilepsy, trigeminal neuralgia, and bipolar demand maintained buying.

Why did the price of Carbamazepine change in Q2 2026 in Germany?

Higher iminodibenzyl synthesis intermediate and energy costs elevated European production economics. Middle East supply disruptions added cost premiums. Recovering epilepsy, trigeminal neuralgia, and bipolar formulation procurement maintained buying near USD 58.2/KG.

Carbamazepine Prices in India

Indian Carbamazepine prices averaged USD 44.9/KG in Q2 2026, up 5.9% from USD 42.4/KG in Q1 2026. Growing epilepsy, trigeminal neuralgia, and anticonvulsant export and domestic demand supported buying. Firmer synthesis import costs raised the production floor.

Why did the price of Carbamazepine change in Q2 2026 in India?

Growing epilepsy and trigeminal neuralgia export and domestic procurement lifted buying. Firmer synthesis import costs raised the production floor. Bipolar disorder and essential medicine export demand provided additional support near USD 44.9/KG.

For the Quarter Ending March 2026

Carbamazepine Prices Q1 2026:

• United States: USD 44.5/KG
• China: USD 30.8/KG
• Germany: USD 54.9/KG
• India: USD 42.4/KG

Carbamazepine Prices in the United States

US prices averaged USD 44.5/KG in Q1 2026, recovering about 2.1% from Q4 2025. Recovering epilepsy and neuralgia demand and firming synthesis costs held the market near USD 44.5/KG.

Why did the price of Carbamazepine change in Q1 2026 in the United States?

Recovering epilepsy and trigeminal neuralgia procurement maintained buying. Firming iminodibenzyl synthesis costs raised the production floor. The market recovered to USD 44.5/KG from the Q4 2025 correction.

Carbamazepine Prices in China

Chinese prices averaged USD 30.8/KG in Q1 2026, recovering about 2.0% from Q4 2025. Post-Lunar New Year epilepsy and neuralgia restocking and firmer synthesis costs held the market near USD 30.8/KG.

Why did the price of Carbamazepine change in Q1 2026 in China?

Post-Lunar New Year epilepsy and neuralgia restocking lifted buying. Firming domestic synthesis costs raised the floor. The market recovered to USD 30.8/KG from the Q4 2025 dip.

Carbamazepine Prices in Germany

German prices averaged USD 54.9/KG in Q1 2026, recovering about 2.0% from Q4 2025. Recovering epilepsy and trigeminal neuralgia demand and firming synthesis and energy costs held the market near USD 54.9/KG.

Why did the price of Carbamazepine change in Q1 2026 in Germany?

Recovering epilepsy, trigeminal neuralgia, and bipolar procurement maintained buying. Firming synthesis and energy costs raised the production floor. The market recovered to USD 54.9/KG from the Q4 2025 correction.

Carbamazepine Prices in India

Indian prices averaged USD 42.4/KG in Q1 2026, recovering about 1.9% from Q4 2025. Growing epilepsy and neuralgia demand and firmer synthesis import costs held the market near USD 42.4/KG.

Why did the price of Carbamazepine change in Q1 2026 in India?

Growing epilepsy and trigeminal neuralgia procurement maintained buying. Firming synthesis import costs raised the floor. The market recovered to USD 42.4/KG from the Q4 2025 correction.

Quarterly Carbamazepine Price Trends

Global Carbamazepine prices rose in Q3 2025 on the anticonvulsant and neuralgia prescription season, dipped in Q4 2025 on synthesis cost moderation, then recovered through Q1 and Q2 2026. The average rose from USD 38.0/KG in Q2 2025 to USD 38.76/KG in Q3, eased to USD 38.37/KG in Q4, then firmed to USD 39.14/KG in Q1 2026 and USD 41.49/KG in Q2 2026, a net gain of about 9.2% over the window. Iminodibenzyl synthesis cost cycles and epilepsy, trigeminal neuralgia, and bipolar procurement drove the overall pattern.

What was Carbamazepine Price in 2025?

Carbamazepine prices firmed modestly through 2025 on consistent epilepsy and trigeminal neuralgia demand. The global average opened near USD 36.8/KG in Q1 2025 and closed at USD 38.37/KG in Q4, a full-year gain of about 4.3%. Synthesis cost dynamics and epilepsy, neuralgia, and bipolar procurement drove the pattern throughout the year.

Carbamazepine Prices in the United States in 2025

US prices firmed from about USD 42.1/KG in Q1 2025 to USD 43.6/KG by Q4, a gain of 3.6%. Consistent epilepsy and trigeminal neuralgia demand maintained the upward trend.

Carbamazepine Prices in China in 2025

Chinese prices firmed from roughly USD 29.2/KG in Q1 2025 to USD 30.2/KG by Q4, a gain of 3.4%. Growing anticonvulsant export and domestic demand drove moderate firming.

Carbamazepine Prices in Germany in 2025

German prices firmed from about USD 52.1/KG in Q1 2025 to USD 53.8/KG by Q4, a gain of 3.3%. Consistent epilepsy and trigeminal neuralgia demand and firm synthesis costs supported the market.

Carbamazepine Prices in India in 2025

Indian prices firmed from roughly USD 40.3/KG in Q1 2025 to USD 41.6/KG by Q4, a gain of 3.2%. Growing anticonvulsant and essential medicine export demand drove consistent firming.

How We Can Help

Expert Market Research: Your Source for Real-Time Carbamazepine Price Intelligence

Expert Market Research tracks Carbamazepine prices continuously across every major producing and consuming region. The team traces causation through iminodibenzyl synthesis intermediate economics, epilepsy and trigeminal neuralgia prescription cycles, and regional API production capacity. Contact Expert Market Research today for Carbamazepine pricing data, bespoke market analysis, and strategic procurement advisory.